Skip to content
Recall Observatory FDA recall evidence

Drug product

Rufinamide Tablets, USP 400 mg, packaged in 120-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-617-08

D-1088-2023

July 21, 2023

Class II

Product summary

Firm
Aurobindo Pharma USA Inc.
Event
Event 92756
Status
Terminated
Classification
Class II
Quantity
48 bottles
Official record key
drug-enforcement:D-1088-2023

Official wording

Reason: cGMP deviations: Batch was released prior to approval.

Code information: Lot #: RB4023002A, Exp 02/2025

Distribution pattern: USA nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP deviations